Literature DB >> 10192500

The antiphospholipid syndrome and 'multiple sclerosis'.

G R Hughes.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10192500     DOI： 10.1191/096120399678847579

Source DB:  PubMed          Journal:  Lupus        ISSN： 0961-2033            Impact factor:   2.911


× No keyword cloud information.
  5 in total

1.  Recurrent transverse myelitis in primary antiphospholipid syndrome--case report and literature review.

Authors:  J H Kim; S I Lee; S I Park; W H Yoo
Journal:  Rheumatol Int       Date:  2003-10-31       Impact factor: 2.631

Review 2.  Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview.

Authors:  Penka A Atanassova
Journal:  Yonsei Med J       Date:  2007-12-31       Impact factor: 2.759

Review 3.  Antiphospholipid antibodies: paradigm in transition.

Authors:  Lawrence L Horstman; Wenche Jy; Carlos J Bidot; Yeon S Ahn; Roger E Kelley; Robert Zivadinov; Amir H Maghzi; Masoud Etemadifar; Seyed Ali Mousavi; Alireza Minagar
Journal:  J Neuroinflammation       Date:  2009-01-20       Impact factor: 8.322

4.  Clinical and neuroimaging correlates of antiphospholipid antibodies in multiple sclerosis: a preliminary study.

Authors:  Carlos J Bidot; Lawrence L Horstman; Wenche Jy; Joaquin J Jimenez; Carlos Bidot; Yeon S Ahn; J Steven Alexander; Eduardo Gonzalez-Toledo; Roger E Kelley; Alireza Minagar
Journal:  BMC Neurol       Date:  2007-10-18       Impact factor: 2.474

5.  Is it necessary to perform connective tissue disorders laboratory tests when a patient experiences the first demyelinating attack?

Authors:  Masoud Etemadifar; Alimohammad Fatemi; Hourossadat Hashemijazi; Amir Kazemizadeh
Journal:  J Res Med Sci       Date:  2013-07       Impact factor: 1.852
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.